Home Vivus: Qsymia Sales Dip - Is A Lower Price Needed?
 

Keywords :   


Vivus: Qsymia Sales Dip - Is A Lower Price Needed?

2015-02-08 09:08:40| Biotech - Topix.net

Vivus investors have seen Qsymia scripts remain in a pretty tight channel for over 15 months. While the sales have remained fairly steady, the arrival of a new competitor could have shifted the market in such a way that Vivus will have little choice but to respond.

Tags: price sales needed lower

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
02.07Levelling up: Can the next government help the UK games industry?
02.07Cheap TVs ahead of Euros help slow price inflation
02.07Hurricane Beryl Graphics
02.07Hurricane Beryl Public Advisory Number 14A
02.07Summary for Hurricane Beryl (AT2/AL022024)
02.07Atlantic Tropical Weather Outlook
02.07Eastern North Pacific Tropical Weather Outlook
02.07Murdoch Netflix rival to launch in UK
More »